Tender Details
Ref No 27150780
Document

Tender Notice

Bidding

Not specified

Short Description

25Bk0129 - Doh Health Facilities Enhancement Program (Hfep) – Lgu Hospitals, Aglipay District Hospital, Quirino
Deadline *
Date 20 May 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Philippines
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

Project More Digital Sao Paulo Project Br L1591

  • Deadline: 28 Dec 2028
  • Ref No: 9868439
  • Location: United States

Open Ended School Based Health Center Services Sbhc Rfp

  • Deadline: 31 Dec 2099
  • Ref No: 8259327
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1

  • Deadline: 10 May 2026
  • Ref No: 8260726
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg

  • Deadline: 10 May 2026
  • Ref No: 3695286
  • Location: United States

Physicians For Utah Labor Commission

  • Deadline: 30 Sep 2031
  • Ref No: 5301821
  • Location: Bulgaria

Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad

  • Deadline: 27 May 2027
  • Ref No: 4717233
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possib

  • Deadline: 31 Dec 2026
  • Ref No: 4722689
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possib

  • Deadline: 31 Dec 2026
  • Ref No: 6479528
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility O

  • Deadline: 31 Dec 2026

Security Assessment Of Facilities

  • Deadline: 07 Dec 2026
  • Ref No: 5976401
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

  • Deadline: 10 May 2026
  • Ref No: 5965319
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine As An Otc Medi

  • Deadline: 10 May 2026
  • Ref No: 5968352
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage

  • Deadline: 10 May 2026
WhatsApp Chat